FDA Warning Letter — Celularity Inc

Case 681480 — FEI 3016661001

The FDA took a Warning Letter action against Celularity Inc on Dec 1, 2025 (Florham Park, NJ). The action was issued by CBER and concerns biologics products. This facility has 4 recent FDA inspections on record.

Action details

Facility
Celularity Inc
Date
Dec 1, 2025
Fiscal Year
2026
Product Type
Biologics
Center
CBER
Location
Florham Park, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.